Skip to main content
. 2019 Jan 16;13:892. doi: 10.3332/ecancer.2019.892

Table 1. Demographic data and treatment features.

Demographic data (n = 299)
Median age 31, 45 years 18–47 years
Median BMI 24 17.4–77.6
Nulliparous (data available only for 184 patients) 148 79%
Hysteroscopic resection prior to medical treatment 4 studies, 76 patients 25%
Pharmacological agents
I. Megestrol Acetate
II. MPA
III. LNG-IUD
IV. Letrozole/Anastrozole
V. GnRH-a (Leuprolide)
VI. Combined Oral Contraceptives
VII. Lynestrenol
VIII. Tamoxifen (always in association with other drugs)
IX. Norethisterone acetate
X. Hydroxyprogesterone caproate

18 studies
14 studies
5 studies
1 study
2 studies
1 study
1 study
2 studies
2 studies
1 study
Median duration of therapy 6 months 2–49 months